Physician

Ahmed Hassaan Qavi, M.D.

According to 2025 Medicare claims, Ahmed Qavi, M.D. (NPI: 1427404565) practices interventional cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is SORIN MEDICAL PC (NPI: 1942543053; TIN: 46-1425115) and primary practice location at 10025-1716. Qavi is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504) and Triad HealthCare Network, LLC. (ACO ID: D0209), participating under both the MSSP and REACH models.

Qavi's data goes back to 2015 and runs through 2024. For example, in 2023, this provider had 23 traditional Medicare patients, billed 23 HCPCS/CPT codes, and received $2,036 in Medicare payments. 2024 Part D data shows 817 prescription claims across 218 beneficiaries totaling $89,886 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 13 claims. Open Payments data shows 33 records totaling $3,167. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,161 to $89,886. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$8.9K$18K2020 Medicare payment: $17,778 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,999 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,036 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020105150$17,778
2021N/RN/RN/R
20223132$3,999
20232323$2,036
2024N/RN/RN/R

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$82K$164K2016 Drug cost: $2,161 (USD; Tot_Drug_Cst)2017 Drug cost: $10,796 (USD; Tot_Drug_Cst)2018 Drug cost: $12,772 (USD; Tot_Drug_Cst)2019 Drug cost: $11,355 (USD; Tot_Drug_Cst)2020 Drug cost: $52,330 (USD; Tot_Drug_Cst)2021 Drug cost: $52,957 (USD; Tot_Drug_Cst)2022 Drug cost: $110,957 (USD; Tot_Drug_Cst)2023 Drug cost: $163,600 (USD; Tot_Drug_Cst)2024 Drug cost: $89,886 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161941$2,161
201751218$10,796
201839222$12,772
201966172$11,355
2020130534$52,330
202169341$52,957
202291513$110,957
2023137758$163,600
2024218817$89,886

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$14K$28K2020 Medicare payment: $164 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $28,142 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $27,494 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R11$164
2021N/R15$28,142
2022N/R13$27,494
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban291,485$25,004
FarxigaDapagliflozin Propanediol21930$17,460
EntrestoSacubitril/Valsartan15540$11,857
Repatha SureclickEvolocumab14560$10,732
BrilintaTicagrelor15488$6,844

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.33$3,167Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ahmed Hassaan Qavi, M.D.?

Tedicare shows public-source Medicare data for Ahmed Hassaan Qavi, M.D. (NPI 1427404565), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmed Hassaan Qavi, M.D. have ACO affiliation data?

Ahmed Hassaan Qavi, M.D. is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504) and Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Ahmed Hassaan Qavi, M.D.?

Ahmed Hassaan Qavi, M.D. is linked to SORIN MEDICAL PC (billing NPI 1942543053) in the available physician profile data.

Does Ahmed Hassaan Qavi, M.D. have Open Payments data?

Ahmed Hassaan Qavi, M.D. has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.